FREE Account Opening + No Clearing Fees
Loading...

Devyani International IPO vs Windlas Biotech IPO

Comparision between Devyani International IPO and Windlas Biotech IPO.

IPO Details

Devyani International IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Windlas Biotech IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Devyani International IPO is up to ₹1,838.00 Cr whereas the issue size of the Windlas Biotech IPO is up to ₹401.54 Cr. The final issue price of Devyani International IPO is ₹90.00 per share and of Windlas Biotech IPO is ₹460.00 per share.

  Devyani International IPO Windlas Biotech IPO
Face Value ₹1 per share ₹5 per share
Issue Price (Lower) ₹86.00 per share ₹448.00 per share
Issue Price (Upper) ₹90.00 per share ₹460.00 per share
Issue Price (Final) ₹90.00 per share ₹460.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 165 shares 30 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹440.00 Cr up to ₹165.00 Cr
OFS Issue Size 15,53,33,330 shares 51,42,067 shares
OFS Issue Size (Amount) up to ₹1,398.00 Cr up to ₹236.54 Cr
Issue Size Total
Issue Size Total (Amount) up to ₹1,838.00 Cr up to ₹401.54 Cr

IPO Timetable

Devyani International IPO opens on Aug 04, 2021, while Windlas Biotech IPO opens on Aug 04, 2021. The closing date of Devyani International IPO and Windlas Biotech IPO is Aug 06, 2021, and Aug 06, 2021, respectively.

  Devyani International IPO Windlas Biotech IPO
Anchor Bid Date
Issue Open Aug 04, 2021 Aug 04, 2021
Issue Close Aug 06, 2021 Aug 06, 2021
Basis Of Allotment (Tentative) Aug 11, 2021 Aug 11, 2021
Initiation of Refunds (Tentative) Aug 12, 2021 Aug 12, 2021
Credit of Share (Tentative) Aug 13, 2021 Aug 13, 2021
Listing date (Tentative) Aug 16, 2021 Aug 16, 2021
Anchor Lockin End date 1 Sep 10, 2021 Sep 10, 2021
Anchor Lockin End date 2 Nov 09, 2021 Nov 09, 2021

Financials

Devyani International IPO P/E ratio is , as compared to Windlas Biotech IPO P/E ratio of .

  Devyani International IPO Windlas Biotech IPO
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 16,684.07 18,835.76 18,074.90
Total Revenue 11,988.95 15,350.41 13,236.83
Profit After Tax (629.87) (1,214.18) (941.44)
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 2,961.23 3,384.88 2,981.80
Total Revenue 4,306.95 3,313.39 3,115.25
Profit After Tax 155.70 162.13 638.22
Promoter Shareholding (Pre-Issue) 75.79% 78%
Promoter Shareholding (Post-Issue) 67.99% 65.16%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Devyani International IPO retail investors (RII) are offered 2,03,67,221 shares while in Windlas Biotech IPO retail investors are offered 2,03,67,221 shares. Qualified institutional buyers (QIB) are offered 6,11,01,666 shares in Devyani International IPO and 17,23,700 shares in Windlas Biotech IPO.

  Devyani International IPO Windlas Biotech IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 6,11,01,666 shares 17,23,700 shares
NII 3,05,50,832 shares 13,23,766 shares
RII 2,03,67,221 shares 30,88,786 shares
Employee 5,50,000 shares 0 shares
Others
Total 11,25,69,719 shares 61,36,252 shares

Bids Received (Subscription)

Devyani International IPO subscribed 116.70x in total, whereas Windlas Biotech IPO subscribed 22.44x.

  Devyani International IPO Windlas Biotech IPO
QIB (times) 95.27x 24.40x
NII (times) 213.06x 15.73x
Big NII (times)
Small NII (times)
RII (times) 39.48x 24.22x
Employee (times) 4.70x
Other (times)
Total (times) 116.70x 22.44x

Comments

Add a public comment...